Societe Generale upgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Sell to Buy with a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments Hot Upgrades Intl Ratings Upgrades